Downregulation of KIF23 suppresses glioma proliferation
- 9 September 2011
- journal article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 106 (3), 519-529
- https://doi.org/10.1007/s11060-011-0706-2
Abstract
To identify therapeutic molecular targets for glioma, we performed modified serological identification of antigens by recombinant complementary DNA (cDNA) expression cloning using sera from a mouse glioma model. Two clones, kinesin family member 23 (Kif23) and structural maintenance of chromosomes 4 (Smc4), were identified as antigens through immunological reaction with sera from mice harboring synergic GL261 mouse glioma and intratumoral inoculation with a mutant herpes simplex virus. The human Kif23 homolog KIF23 is a nuclear protein that localizes to the interzone of mitotic spindles, acting as a plus-end-directed motor enzyme that moves antiparallel microtubules in vitro. Expression analysis revealed a higher level of KIF23 expression in glioma tissues than in normal brain tissue. The introduction of small interfering RNA (siRNA) targeting KIF23 into two different glioma cell lines, U87MG and SF126, downregulated KIF23 expression, which significantly suppressed glioma cell proliferation in vitro. KIF23 siRNA-treated glioma cells exhibited larger cell bodies with two or more nuclei compared with control cells. In vivo analysis using mouse xenograft showed that KIF23 siRNA/DNA chimera-treated tumors were significantly smaller than tumors treated with control siRNA/DNA chimera. Taken together, our results indicate that downregulation of KIF23 decreases proliferation of glioma cells and that KIF23 may be a novel therapeutic target in malignant glioma.Keywords
This publication has 51 references indexed in Scilit:
- Functional analysis of HOXD9 in human gliomas and glioma cancer stem cellsMolecular Cancer, 2011
- Ongoing and future developments at the Universal Protein ResourceNucleic Acids Research, 2010
- Infrastructure for the life sciences: design and implementation of the UniProt websiteBMC Bioinformatics, 2009
- CUX1 and E2F1 Regulate Coordinated Expression of the Mitotic Complex Genes Ect2, MgcRacGAP, and MKLP1 in S PhaseMolecular and Cellular Biology, 2009
- Functional dissection of siRNA sequence by systematic DNA substitution: modified siRNA with a DNA seed arm is a powerful tool for mammalian gene silencing with significantly reduced off-target effectNucleic Acids Research, 2008
- Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-primingProceedings of the National Academy of Sciences of the United States of America, 2007
- The nuclear localization signal of mitotic kinesin-like protein Mklp-1: Effect on Mklp-1 function during cytokinesisBiochemical and Biophysical Research Communications, 2007
- Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patientsProceedings of the National Academy of Sciences of the United States of America, 2006
- CHO1, a mammalian kinesin-like protein, interacts with F-actin and is involved in the terminal phase of cytokinesisThe Journal of cell biology, 2002
- A plus-end-directed motor enzyme that moves antiparallel microtubules in vitro localizes to the interzone of mitotic spindlesNature, 1992